AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MICROSAIC SYSTEMS PLC

Delisting Announcement Nov 12, 2024

7786_rns_2024-11-12_836b1341-5bc6-4d86-a324-746bf4c6f7c5.html

Delisting Announcement

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 8664L

Microsaic Systems plc

12 November 2024

12 November 2024

Microsaic Systems plc

("Microsaic" or the "Company")

Restoration of Company's Shares to Trading on AIM

Following the publication of its H1 24 interim results on 12 November 2024, Microsaic Systems plc (AIM: MSYS), an international developer and provider of testing solutions for unique and underserved public health and environmental markets, confirms that its ordinary shares are expected to be restored to trading on AIM at 7.30 a.m. today.

Microsaic Systems plc

Bob Moore, Acting Executive Chairman
+44 (0) 20 3657 0050

via TPI
Singer Capital Markets (Nominated Adviser)

Alex Bond / Oliver Platts
+44 (0)20 7496 3000
Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker / James Pope
+44 (0) 20 3657 0050

About Microsaic Systems

Microsaic is highly experienced in the development, manufacture and supply of microelectronics instrumentation for markets requiring analytical testing in public and environmental health markets. The Company has recently acquired and integrated the assets of Modern Water with Microsaic Systems' technologies resulting in comprehensive water testing and other toxic testing capabilities.

Microsaic's products and solutions are commercially available through global markets via a network of regional and country specific distributors and partners.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RENGPGPPGUPCUMP

Talk to a Data Expert

Have a question? We'll get back to you promptly.